| Dr Farooq A Mirza, MD | |
|
309 11th St, Carrollton, KY 41008-1435 | |
| (502) 732-3799 | |
| (502) 732-8551 |
| Full Name | Dr Farooq A Mirza |
|---|---|
| Gender | Male |
| Speciality | Surgery |
| Location | 309 11th St, Carrollton, Kentucky |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245259910 | NPI | - | NPPES |
| 20006 | Other | KY | STATE LICENSE NUMBER |
| 64866247 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 44235 (Ohio) | Secondary |
| 208600000X | Surgery | 20006 (Kentucky) | Primary |
| Entity Name | Ccmh Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225159601 PECOS PAC ID: 2365540465 Enrollment ID: O20080108000723 |
News Archive
CoActiv Medical debuts at the 2013 Radiological Society of North America conference EXAM-PACS version 3.0. CoActiv leverages its longstanding experience with standards-based technology to bring new market-leading features and functionality to its flagship enterprise PACS and to provide more options and flexibility across the entire product line with expanded deployment options and a more robust vendor neutral archive.
Javelin Pharmaceuticals, Inc., a leading developer and marketer of specialty pharmaceutical products for pain management, today announced that its New Drug Application (NDA) submitted on December 2, 2009 to the US Food and Drug Administration (FDA) for its investigational product candidate, Dyloject™ (diclofenac sodium) Injection, has received an FDA PDUFA date of October 3, 2010. This NDA review is in support of US marketing approval and registration of Dyloject for the management of acute moderate-to-severe pain in adults.
People's willingness to use a Zika vaccine when it's available will be influenced by how they weigh the risks associated with the disease and the vaccine, but also by their misconceptions about other vaccines, a new study has found.
New York State's attorney general filed an antitrust lawsuit on Monday seeking to stop a pharmaceutical company from forcing patients with Alzheimer's disease to switch to a new version of a widely used drug. The lawsuit contends that the switch is designed to blunt competition from low-priced generic versions of the medication (Pollack, 9/15).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Farooq A Mirza, MD 309 11th St, Carrollton, KY 41008-1435 Ph: (502) 732-3799 | Dr Farooq A Mirza, MD 309 11th St, Carrollton, KY 41008-1435 Ph: (502) 732-3799 |
News Archive
CoActiv Medical debuts at the 2013 Radiological Society of North America conference EXAM-PACS version 3.0. CoActiv leverages its longstanding experience with standards-based technology to bring new market-leading features and functionality to its flagship enterprise PACS and to provide more options and flexibility across the entire product line with expanded deployment options and a more robust vendor neutral archive.
Javelin Pharmaceuticals, Inc., a leading developer and marketer of specialty pharmaceutical products for pain management, today announced that its New Drug Application (NDA) submitted on December 2, 2009 to the US Food and Drug Administration (FDA) for its investigational product candidate, Dyloject™ (diclofenac sodium) Injection, has received an FDA PDUFA date of October 3, 2010. This NDA review is in support of US marketing approval and registration of Dyloject for the management of acute moderate-to-severe pain in adults.
People's willingness to use a Zika vaccine when it's available will be influenced by how they weigh the risks associated with the disease and the vaccine, but also by their misconceptions about other vaccines, a new study has found.
New York State's attorney general filed an antitrust lawsuit on Monday seeking to stop a pharmaceutical company from forcing patients with Alzheimer's disease to switch to a new version of a widely used drug. The lawsuit contends that the switch is designed to blunt competition from low-priced generic versions of the medication (Pollack, 9/15).
› Verified 6 days ago
Jeannine Marie Perrenoud, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 329 Floyd Dr, Carrollton, KY 41008 Phone: 502-732-3270 | |
Patricia L Figert, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 309 11th St, Carrollton, KY 41008 Phone: 502-732-3204 Fax: 502-732-3213 |